FDAClass IIMay 4, 2022

NAD+ Nicotinamide Adenine Dinucleotide Lyophilized recall

NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose 500 mg Per Vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy…

Why was NAD+ Nicotinamide Adenine Dinucleotide Lyophilized recalled?

Failed Reconstitution time

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot: F41116 BUD: 6/16/2022,

Product
NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose 500 mg Per Vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy…
Recalling firm
Olympia Compounding Pharmacy dba Olympia Pharmacy
Distribution
Distributed Nationwide in the USA
Recall date
May 4, 2022
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls